Abiopharma

New Form SCHEDULE 13G/A - RHYTHM PHARMACEUTICALS, INC. Filed: 2025-05-15 AccNo: 0001104659-25-049479 Size: 15 KB

Vivos Therapeutics Reports First Quarter 2025 Financial Results and Provides Operational Update

New Form 4 - Arcutis Biotherapeutics, Inc. Filed: 2025-05-15 AccNo: 0001415889-25-013137 Size: 11 KB

New Form SCHEDULE 13G - CONDUIT PHARMACEUTICALS INC. Filed: 2025-05-15 AccNo: 0001641172-25-010946 Size: 13 KB

New Form 8-K - Rein Therapeutics, Inc. Filed: 2025-05-15 AccNo: 0001193125-25-120824 Size: 253 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits

New Form 4 - Phathom Pharmaceuticals, Inc. Filed: 2025-05-15 AccNo: 0001415889-25-013134 Size: 11 KB

New Form 8-K - Fulgent Genetics, Inc. Filed: 2025-05-15 AccNo: 0000950170-25-072676 Size: 200 KB Item 5.07: Submission of Matters to a Vote of Security Holders

P3 Health Partners Announces First Quarter 2025 Results

New Form 6-K - TRINITY BIOTECH PLC Filed: 2025-05-15 AccNo: 0001178913-25-001821 Size: 1 MB

New Form 4 - ELI LILLY & Co Filed: 2025-05-15 AccNo: 0000059478-25-000144 Size: 4 KB

New Form 8-K - Safety Shot, Inc. Filed: 2025-05-15 AccNo: 0001641172-25-010941 Size: 554 KB Item 1.01: Entry into a Material Definitive Agreement Item 9.01: Financial Statements and Exhibits

New Form 4 - Alto Neuroscience, Inc. Filed: 2025-05-15 AccNo: 0001999480-25-000040 Size: 5 KB

New Form 8-K - P3 Health Partners Inc. Filed: 2025-05-15 AccNo: 0001628280-25-025928 Size: 898 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits

New Form 4 - Alto Neuroscience, Inc. Filed: 2025-05-15 AccNo: 0001999480-25-000041 Size: 5 KB

New Form SCHEDULE 13G/A - ORASURE TECHNOLOGIES INC Filed: 2025-05-15 AccNo: 0001654954-25-005755 Size: 113 KB